Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 26, 2019Current Pharmaceutical DesignOpen Access

A Brief Review of Cardiovascular Diseases, Associated Risk Factors and Current Treatment Regimes

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Cardiovascular diseases are the leading cause of premature death globally, and despite effective therapies, significant gaps in the treatment of CVDs remain.

Design

Review

Authors

GFGagan D. FloraUniversity of IowaMNManasa K. NayakUniversity of Iowa

Discussion

Loading...

Member takes

Implication

Reaffirms modifiable factors drive most CVD; leaves open strategies to close persistent global treatment gaps.

Key Points

  • This review aims to explore the epidemiology, pathology, and treatment of cardiovascular diseases (CVDs).
  • Comprehensive literature review on cardiovascular diseases and associated risk factors.
  • Analysis of the socio-economic impact and global prevalence of CVDs.
  • Discussion of treatment regimes and their effectiveness.
  • Cardiovascular diseases account for a leading cause of death and disability worldwide.
  • More than 90% of CVD risks are attributed to factors like hyperlipidaemia and hypertension.
  • Gaps in effective treatment persist despite existing therapies.

Cite This Study

Flora et al. (2019) studied this question.

synapsesocial.com/papers/69de5043e02db3e29db0c03ehttps://doi.org/10.2174/1381612825666190925163827

Topics

Hypertension managementCardiovascular preventionCOVID-19 cardiovascular
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Heart Disease and Stroke Statistics—2016 Update2015 · 6,663 citations
  2. 2Heart Disease and Stroke Statistics—2011 Update2010 · 6,173 citations
  3. 3The genetics of familial hypercholesterolemia and emerging therapies2015 · 47 citations
  4. 42014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults2013 · 8,070 citations
  5. 5Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes2015 · 4,528 citations